Erdafitinib
152 interactions 68 cited referencesErdafitinib is used to treat certain types of urothelial cancer (cancer of the lining of the bladder and other parts of the urinary tract) that spread to nearby tissues or other parts of the body that cannot be removed by surgery and has worsened during or after being treated with other chemotherapy medications. Erdafi… Read the full Erdafitinib drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Contraindicated
Erdafitinib Bacillus Of Calmette And Guerin Vaccine, Live An increased risk of infection by the live vaccine Details Erdafitinib Dengue Tetravalent Vaccine, Live An increased risk of infection by the live vaccine Details Erdafitinib Ensitrelvir Increased CYP3A substrates exposure and an increased risk of CYP3A substrates-related adverse effects Details Erdafitinib Measles Virus Vaccine, Live An increased risk of infection by the live vaccine Details Erdafitinib Mumps Virus Vaccine, Live An increased risk of infection by the live vaccine Details Erdafitinib Rubella Virus Vaccine, Live An increased risk of infection by the live vaccine Details Erdafitinib Smallpox Monkeypox Vaccine An increased risk of infection by the live vaccine Details Erdafitinib Typhoid Vaccine Typhim VI® An increased risk of infection by the live vaccine Details Erdafitinib Varicella Virus Vaccine, Live An increased risk of infection by the live vaccine Details Erdafitinib Yellow Fever Vaccine Stamaril An increased risk of infection by the live vaccine DetailsMajor
Erdafitinib Colchicine Colcrys Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Erdafitinib Capecitabine Xeloda Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Erdafitinib Cyclosporine Injection Atopica Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Erdafitinib Cyclosporine Ophthalmic Cequa Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Erdafitinib Digoxin Cardoxin® Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Erdafitinib Adagrasib Krazati Increased erdafitinib exposure Details Erdafitinib Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Erdafitinib Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Erdafitinib Alfentanil Increased ALfentanil exposure and an increased risk of respiratory depression Details Erdafitinib Aluminum Carbonate, Basic Altered serum phosphate levels Details Erdafitinib Aluminum Hydroxide AlternaGEL® Altered serum phosphate levels Details Erdafitinib Aluminum Phosphate Altered serum phosphate levels Details Erdafitinib Amiodarone Nexterone Increased erdafitinib exposure Details Erdafitinib Apalutamide Erleada Reduced erdafitinib exposure Details Erdafitinib Artemether Increased artemether/lumefantrine exposure, an increased risk of QT prolongation, reduced CYP3A4 substrate exposure and reduced ef... Details Erdafitinib Boceprevir Increased erdafitinib exposure Details Erdafitinib Bosentan Reduced erdafitinib exposure Details Erdafitinib Calcium Acetate Calphron Altered serum phosphate levels Details Erdafitinib Calcium Carbonate Alka-Mints Altered serum phosphate levels Details Erdafitinib Calcium Chloride Altered serum phosphate levels Details Erdafitinib Calcium Citrate Altered serum phosphate levels Details Erdafitinib Calcium Gluconate Calgonate Altered serum phosphate levels Details Erdafitinib Cannabidiol Epidiolex Increased erdafitinib exposure Details Erdafitinib Carbamazepine Carbatrol Reduced erdafitinib exposure Details Erdafitinib Cenobamate Xcopri Reduced erdafitinib exposure Details Erdafitinib Ceritinib Zykadia Increased erdafitinib exposure Details Erdafitinib Cholecalciferol Altered serum phosphate levels Details Erdafitinib Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Erdafitinib Clarithromycin Biaxin Increased erdafitinib exposure Details Erdafitinib Cobicistat Tybost Increased erdafitinib exposure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist